Emerging Managers

Life sciences-focused venBio raises $315 mln for second fund

San Francisco-based venBio Partners announced it has raised $315 million for its second life science fund, which is anchored by investments from strategic LPs Amgen, Merck and Baxalta. The amount exceeds the $250 million target it set in March 2015, according to a regulatory filing. The firm, which also has an office in New York, typically invests in clinical-stage life science companies with a therapeutic product.

Partner dispute roils Xfund

A dispute between general partners has roiled operations at the Xfund, according to reports in The New York Times and Fortune.

Consumer tech-focused Binary Capital seeks second fund

San Francisco-based Binary Capital, which raised $125 million for its debut fund in 2014, is seeking a second fund. No target is listed on the firm's regulatory document.

Boston's .406 Ventures seeks $80 mln for its first opportunity fund

Boston-based .406 Ventures, which last year closed its third early-stage fund with $217 million in commitments, has filed to raise $80 million for an opportunity fund, according to a regulatory document.

Recap: Worldwide fundraising news

A summary of recent fundraising closes from around the world, with Excel tables

A smart Endeavour builds up its medtech vision with large fund

Pure-play medtech funds are rare, but one firm has breezed to its first despite a leap in investment-stage focus

Boston-based Pillar aims to raise $100 mln for inaugural fund

Jamie Goldstein, a former general partner with North Bridge Venture Partners, has filed to raised $100 million for his new Boston-based fund Pillar I, according to a regulatory filing.

Boston-based Pillar aims to raise $100 mln for inaugural fund

Jamie Goldstein, a former general partner with North Bridge Venture Partners, has filed to raised $100 million for his new Boston-based fund Pillar I, according to a regulatory filing.

From Array to Zetta, plenty more firms in fundraising mode

A number of firms, many of them emerging managers, have filed regulatory documents indicating their intent to raise new funds or they have reported initial closes

CrunchFund seeks $30 mln for third fund

CrunchFund, the early-stage venture firm founded by TechCrunch's Michael Arrington in 2011, has filed to raise $30 million for its third fund, according to a regulatory filing.